These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 14971049

  • 1. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M, Lang R, Binda E, Panina-Bordignon P, D'Ambrosio D.
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B, Morel E, Martín-Díaz MA, Díaz R, Alves-Ferreira J, Rubio P, Padial A, Bellón T.
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [Abstract] [Full Text] [Related]

  • 3. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
    Iellem A, Colantonio L, D'Ambrosio D.
    Eur J Immunol; 2003 Jun; 33(6):1488-96. PubMed ID: 12778466
    [Abstract] [Full Text] [Related]

  • 4. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
    Shimauchi T, Imai S, Hino R, Tokura Y.
    Clin Cancer Res; 2005 Mar 15; 11(6):2427-35. PubMed ID: 15788694
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors.
    Kobayashi M, Shimauchi T, Hino R, Tokura Y.
    Cell Immunol; 2004 Mar 15; 228(1):27-33. PubMed ID: 15203317
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo.
    Biedermann T, Schwärzler C, Lametschwandtner G, Thoma G, Carballido-Perrig N, Kund J, de Vries JE, Rot A, Carballido JM.
    Eur J Immunol; 2002 Nov 15; 32(11):3171-80. PubMed ID: 12555662
    [Abstract] [Full Text] [Related]

  • 10. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
    Bochner BS, Hudson SA, Xiao HQ, Liu MC.
    J Allergy Clin Immunol; 2003 Nov 15; 112(5):930-4. PubMed ID: 14610482
    [Abstract] [Full Text] [Related]

  • 11. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.
    Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC.
    Nature; 1999 Aug 19; 400(6746):776-80. PubMed ID: 10466728
    [Abstract] [Full Text] [Related]

  • 12. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F, Hoogsteden HC, Coyle AJ, Lambrecht BN, Hammad H.
    Allergy; 2009 Jul 19; 64(7):995-1002. PubMed ID: 19630858
    [Abstract] [Full Text] [Related]

  • 13. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion.
    D'Ambrosio D, Albanesi C, Lang R, Girolomoni G, Sinigaglia F, Laudanna C.
    J Immunol; 2002 Sep 01; 169(5):2303-12. PubMed ID: 12193695
    [Abstract] [Full Text] [Related]

  • 14. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
    Morimoto Y, Bian Y, Gao P, Yashiro-Ohtani Y, Zhou XY, Ono S, Nakahara H, Kogo M, Hamaoka T, Fujiwara H.
    J Leukoc Biol; 2005 Sep 01; 78(3):753-61. PubMed ID: 16126843
    [Abstract] [Full Text] [Related]

  • 15. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
    Belperio JA, Dy M, Murray L, Burdick MD, Xue YY, Strieter RM, Keane MP.
    J Immunol; 2004 Oct 01; 173(7):4692-8. PubMed ID: 15383605
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
    Cronshaw DG, Kouroumalis A, Parry R, Webb A, Brown Z, Ward SG.
    J Leukoc Biol; 2006 Jun 01; 79(6):1369-80. PubMed ID: 16614259
    [Abstract] [Full Text] [Related]

  • 18. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
    Vestergaard C, Deleuran M, Gesser B, Larsen CG.
    Exp Dermatol; 2004 Apr 01; 13(4):265-71. PubMed ID: 15086343
    [Abstract] [Full Text] [Related]

  • 19. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK, Newton SB, Bach TL, Budgin JB, Benoit BM, Lin JH, Yoon JS, Wysocka M, Abrams CS, Rook AH.
    Am J Hematol; 2007 Sep 01; 82(9):792-7. PubMed ID: 17546636
    [Abstract] [Full Text] [Related]

  • 20. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.
    Sebastiani S, Danelon G, Gerber B, Uguccioni M.
    Eur J Immunol; 2005 Mar 01; 35(3):746-56. PubMed ID: 15714581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.